Consequences of Undiagnosed and Untreated Pain

Published Online: Thursday, October 20, 2011
Follow Pharmacy_Times:
Watch as Michael R. Clark, MD, MPH, MBA, associate professor and director of the Chronic Pain Treatment Programs and department of Psychiatry and Behavioral Sciences at Johns Hopkins Medical Institutions, talks about the consequences of pain going undiagnosed or untreated—particularly in terms of the impact on quality of life, and the importance of engaging patients early.

Related Articles
Not every patient requires an aspirin a day.
The rate of deaths from opiate medications in the United States has increased 4-fold over the past decade.
Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.
Community pharmacists can identify and educate patients at high risk for acute kidney injury related to use of nonsteroidal anti-inflammatory drugs.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$